MDxHealth SA (MDXH)

NASDAQ: MDXH · IEX Real-Time Price · USD
6.75
+0.08 (1.20%)
At close: Sep 29, 2022 4:00 PM
6.62
-0.13 (-1.93%)
After-hours: Sep 29, 2022 4:00 PM EDT
1.20%
Market Cap 107.84M
Revenue (ttm) 22.24M
Net Income (ttm) -29.00M
Shares Out 15.98M
EPS (ttm) -2.26
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 569
Open 6.75
Previous Close 6.67
Day's Range 6.38 - 6.75
52-Week Range 6.00 - 13.17
Beta 0.91
Analysts Buy
Price Target 15.73 (+133.0%)
Earnings Date Aug 17, 2022

About MDXH

MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, the Netherlands, Belgium, Spain, Poland, Italy, rest of European Union, and internationally. Its novel prostate cancer genomic testing solutions are SelectMDx, a non-invasive urine test; and ConfirmMDx, an epigenetic test, which provide physicians with a clinical pathway to identify clinically prostate cancer while minimizing the use of invasive procedures that are prone to complications. The company was formerly known as OncoMethyl... [Read more...]

Industry Diagnostics & Research
IPO Date Nov 4, 2021
CEO Michael McGarrity
Employees 191
Stock Exchange NASDAQ
Ticker Symbol MDXH
Full Company Profile

Financial Performance

In 2021, MDxHealth's revenue was $22.24 million, an increase of 20.47% compared to the previous year's $18.46 million. Losses were -$29.00 million, 1.19% more than in 2020.

Financial Statements

Analyst Forecast

According to 9 analysts, the average rating for MDXH stock is "Buy." The 12-month stock price forecast is 15.73, which is an increase of 133.04% from the latest price.

Price Target
$15.73
(133.04% upside)
Analyst Consensus: Buy
Stock Forecasts

News

MDxHealth Reports Half Year 2022 Results

NEWS RELEASE - REGULATED INFORMATION25 AUGUST 2022, 4:00PM EDT, 22:00 CET

1 month ago - GlobeNewsWire

Mdxhealth's New Share Capital Amount and New Number of Shares

NEWS RELEASE - REGULATED INFORMATION August 19 , 2022 , 4:00 PM EDT / 22:00 CET

1 month ago - GlobeNewsWire

Is a Surprise Coming for MDxHealth (MDXH) This Earnings Season?

MDxHealth (MDXH) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

1 month ago - Zacks Investment Research

MDxHealth Announces Results of its Annual and Extraordinary General Shareholders' Meetings and Resignation of Director

NEWS RELEASE - REGULATED INFORMATION                 25 May 2022 , 4:00 p.m. EDT / 22:00 CET

4 months ago - GlobeNewsWire

MDxHealth Reports Q1-2022 Results

NEWS RELEASE - REGULATED INFORMATION 27 APRIL 202 2 , 4:00PM EDT / 22:00 CET

5 months ago - GlobeNewsWire

MDxHealth Announces its Ordinary and Extraordinary General Shareholders' Meetings

NEWS RELEASE - REGULATED INFORMATION                 25 April 2022 , 10:00 p.m. CET

5 months ago - GlobeNewsWire

MDxHealth to Participate in the 14th Annual Kempen Life Sciences Conference

NEWS RELEASE March 30, 2022, 4: 3 0 PM EST / 22: 3 0 CET

6 months ago - GlobeNewsWire

MDxHealth Reports Financial Year 2021 Results and Provides Outlook and Guidance for 2022

NEWS RELEASE - REGULATED INFORMATION 2 MARCH 202 2 , 4 : 0 0 PM EST / 22:00 CET

7 months ago - GlobeNewsWire

MDxHealth to Present Fourth Quarter and Full Year 2021 Financial Results and Corporate Update on March 2nd

NEWS RELEASE 17 February 2022, 4:00 PM EST / 22:00 CET

7 months ago - GlobeNewsWire

MDxHealth to Present at BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

NEWS RELEASE 9 FEBRUARY 2022, 4:00 PM EST / 22:00 CET

7 months ago - GlobeNewsWire

MDxHealth Shareholder Transparency Declaration

NEWS RELEASE – REGULATED INFORMATION 10 December 2021, 23:55 CET

9 months ago - GlobeNewsWire

MDxHealth Announces Completion of Initial Public Offering of ADSs in the United States

NEWS RELEASE – REGULATED INFORMATION         15 November 2021 , 11:00 p .m. CET

10 months ago - GlobeNewsWire

MDxHealth Announces Pricing of Initial Public Offering of ADSs in the United States

NEWS RELEASE - REGULATED INFORMATION INSIDE INFORMATION 4 NOVEMBER 2021, 13:00 CET

10 months ago - GlobeNewsWire

MDxHealth Announces Launch of Proposed Initial Public Offering of ADSs in the United States

NEWS RELEASE - REGULATED INFORMATION INSIDE INFORMATION 28 OCTOBER 2021, 07:00 CEST

11 months ago - GlobeNewsWire